3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
15
Prostatic Neoplasms
10
Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
4
Triple Negative Breast Neoplasms
3
Ovarian Neoplasms
3
Myelodysplastic Syndromes
3
Endometrial Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Cardiovascular Diseases
3
Cardiotoxicity
3
Rectal Neoplasms
2
Polycystic Ovary Syndrome
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Leukemia
2
Kidney Neoplasms
2
Heart Failure
2
Head and Neck Neoplasms
2
Glioblastoma
2
Endometrial Hyperplasia
2
Carcinoma, Renal Cell
2
Waldenstrom Macroglobulinemia
1
Venous Thrombosis
1
Urogenital Neoplasms
1
Smoking
1
Interventions
XENP 1595
2
mazdutide
1
enzalutamide
1
amlodipine, atorvastatin drug combination
1
UE2343
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed
1
Tablets
1
Standard of Care
1
Referral and Consultation
1
Prednisone
1
Positron-Emission Tomography
1
Methods
1
Magnetic Resonance Imaging
1
Lysine Acetyltransferase 5
1
Hormones
1
Gonadotropin-Releasing Hormone
1
Exercise
1
Ethanol
1
Electroencephalography
1
Dignity Therapy
1
Decision Support Techniques
1
Atorvastatin
1
Activities of Daily Living
1
Accidental Falls
1
Abiraterone Acetate
1
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Dementia
×
Atorvastatin
×
Clear all
NCT02099123
2024-11-21
STAREE
Monash University
Phase 4
Active not recruiting
9,971 enrolled